Due to the unique properties of PNP, installing poly(lactic-co-glycolic acid) (PLGA) with BCMA72-80 has increased the uptake of peptides by antigen-presenting cells compared to lipid-based delivery systems and induced BCMA-specific cytotoxic T lymphocytes with higher anti-tumor activity, providing direction for the development of PLGA-based MM therapeutic drugs [81]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.